SG Healthcare Executive Im Jae-hyeon Increases Stake by 0.04% via Stock Purchase Right Exercise

SG Healthcare registered executive Vice President Im Jae-hyeon exercised stock purchase rights on July 7, 2026, acquiring 6,250 common shares.
The acquisition price of 1,750 KRW per share is approximately 15% below the closing price of 2,060 KRW on the reporting date, increasing his stake from 0.25% to 0.29%.
The increase represents only 0.04% of total outstanding shares, resulting in negligible impact on stock price or corporate governance.
[AI Summary]Vice President Im Jae-hyeon’s minor stake increase could be interpreted as a signal of management confidence, but the very small size limits its market impact. The stock purchase right exercise appears part of standard executive incentive arrangements.